senkyunolide H

from Ligusticum chuanxiong; structure nin first source

Networked: 3 relevant articles (1 outcomes, 1 trials/studies)

1.	Ischemic Stroke 01/01/2019 - "Senkyunolide-H (SEH), a major bioactive compound extracted from Ligusticum chuanxiong, has been reported to be effective in preventing cerebral ischemic stroke (CIS). "
2.	Osteoporosis 12/10/2020 - "Accordingly, in this study, we investigated the effects of senkyunolide H (SNH), an active component extracted from ligusticum chuanxiong Hort, on osteoporosis through a series of in vivo and in vitro experiments. "
3.	Postmenopausal Osteoporosis 12/10/2020 - "Senkyunolide H attenuates osteoclastogenesis and postmenopausal osteoporosis by regulating the NF-κB, JNK and ERK signaling pathways."
4.	Neuroinflammatory Diseases 04/01/2022 - "Senkyunolide H inhibits activation of microglia and attenuates lipopolysaccharide-mediated neuroinflammation and oxidative stress in BV2 microglia cells via regulating ERK and NF-κB pathway."

1.	Lipopolysaccharides